Skip to main content

Table 1 GEO identifiers and data sets used for pathway activation method comparison

From: Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways

GEO ID

Subgroup 1 (Baseline)

Subgroup 2

GDS1062

Metastasis-negative squamous cell carcinoma (8)

Metastasis-positive squamous cell carcinoma (14)

GDS1067

Monoclonal gammopathy (7)

Multiple myeloma (39)

GDS1210

Normal gastric tissue (8)

Gastric carcinoma (14)

GDS1220

Normal pleural tissue (8)

Malignant mesothelioma (40)

GDS1221

Peripheral blood, CML responsive Gleevec (9)

Peripheral blood, CML not responsive Gleevec (7)

GDS1231

Enriched for hematopoietic stem cells (9)

Enriched for committed hematopoietic cells (9)

GDS1329

'Basal' breast tumors (16)

'Luminal' breast tumors (27)

GDS1329

'Basal' breast tumors (16)

'Apocrine' breast tumors (6)

GDS1332

Whole blood normal controls (14)

Whole blood symptomatic Huntington disease (12)

  1. The numbers in parentheses are the number of samples in each subgroup. CML, chronic myelogenous leukemia. References are provided in the main text.